The utility of remdesivir in SARS-CoV-2: A single tertiary care center experience from a developing country
Background: Remdesivir is a monophosphoramidate prodrug of an adenosine analog, and it has a broad-spectrum antiviral activity against paramyxoviruses, flaviviruses, and coronaviruses. Remdesivir is associated with decreased hospital stay and improved outcomes in coronavirus- disease 2019 (COVID-19)...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Exploratory Research in Clinical and Social Pharmacy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667276622000063 |